Introduction
Examination of the eye is a fundamental part of the evaluation of a patient with suspected systemic illness. The combination of a peculiar mixture of the ability to directly visualize the vasculature directly and the propensity for ocular structures or the neurological connexions of the eye to fall foul of systemic disease mean that the symptoms or signs relating to the eye are often the initial manifestation of serious systemic illness. As a consequence, expertise in the examination of the eyes became a major feature of clinical examination for physicians in the 19th and 20th centuries with numerous physical signs and eponymous syndromes relating to the eye in existence. Sadly, nowadays the examination of the eye is not always in the pantheon of the trainee in general medicine; the MRCP PACES examination no longer has a mandatory ocular examination (http://www .mrcpuk.org/PACES/Pages/PacesFormat.aspx), and routine fundoscopy through dilated pupils performed by a medical practitioner is no longer a regular component of diabetes clinical management in the UK (http://www.scotland.gov.uk/Resource/Doc/321699/ 0103402.pdf).
However, careful examination of the eyes can often detect subtle findings that provide invaluable information to complement laboratory examinations and non-invasive imaging and allow for accurate interpretation of these results in complex clinical circumstances.
Case report 1
A 51-year-old woman was admitted to hospital as an emergency for the investigation of dyspnoea and facial discomfort. Nine months prior to this presentation she had been diagnosed with breast carcinoma and had undergone a right-sided lumpectomy and axillary clearance. The tumour was ER positive and the patient was post-menopausal. She subsequently received loco-regional radiotherapy and systemic chemotherapy with good initial clinical response. There was no other personal medical history of note. In particular, she was a non-smoker with no history of cardiovascular disease, hypertension or diabetes.
Two months prior to this admission, the patient had presented to her local emergency department complaining of dyspnoea on exertion. Clinical evaluation was reported as unremarkable, but laboratory investigations revealed an elevated plasma D-dimer concentration and as a consequence a computed axial tomograpy (CT) pulmonary angiogram was performed, which failed to demonstrate evidence of proximal pulmonary thromboembolism not to intra-thoracic metastatic disease. No further action was taken and the patient was discharged without follow-up or explanation of her symptoms.
Her symptoms did not resolve and at the time of her re-evaluation she was dyspnoeic at rest. She denied orthopnoea or paroxysmal dyspnoea or chest pain. However, on further questioning she volunteered that she had noticed a sudden reduction in vision in her left eye in the 24 h from referral to in-hospital senior review. The patient described an inferior altitudinal uniocular visual loss that had not recovered 12 h after it commenced. Visual acuity in the left eye was 6/60, 6/6 in the right. Both anterior segments were clear with no evidence of inflammation or acute glaucoma. Examination of the pupillary responses revealed the presence of a left relative afferent pupillary defect (RAPD) and ophthalmoscopy of the fundi showed no evidence of optic nerve pathology and there were no vascular changes noted in the retina.
Laboratory investigations revealed a persistent elevation in plasma D-dimer with other abnormal features in her coagulation profile suggesting the presence of chronic disseminated intravascular coagulation (DIC) ( Table 1) . At this stage, the diagnosis of acute ischaemic optic neuropathy (ION) secondary to underlying chronic DIC was made. Treatment with intravenous unfractionated heparin was introduced and the dose titrated against the level of plasma fibrinogen and activated partial thromboplastin time (APTT) until fibrinogen levels normalized and oral anticoagulation with warfarin was introduced. The visual acuity in the left eye remained poor at 6/48 and the afferent pupillary defect also persisted. The patients dyspnoea improved as did indices of gas exchange consistent with an improvement in pulmonary perfusion (Table 1) A further CT of the thorax and abdomen showed no evidence of metastatic breast carcinoma, but an examination of the bone marrow revealed the presence of metastatic breast carcinoma ( Figure 1 ). The patient opted to receive further systemic chemotherapy, but died 7 months after this presentation.
Case report 2
An 82-year-old woman was admitted as an emergency because of headache and visual loss in the right eye. She had noted facial pain and absence of sight in the right eye for $1 month prior to admission, but was unclear if there had been progressive visual decline prior to this. She had oEstrogen Receptor (ER)-positive breast cancer diagnosed 6 years previously and had been managed with oral tamoxifen. Systemic enquiry was unremarkable, but she did have a history of hypertension and received bendroflumethiazide and amlodipine.
Examination revealed a large visual field defect affecting the right eye only with visual acuity 6/60 in the right eye, 6/12 in the left eye. Examination of the pupillary responses revealed a right RAPD.
There was no limitation of extra ocular eye movements and fundoscopy revealed mild optic atrophy and grade 2 hypertensive changes in the right eye, with grade 2 hypertensive change in the left eye. The combination of a right RAPD and profound visual loss prompted investigation with cranial magnetic resonance imaging (MRI), which revealed the presence of a lesion at the right orbital apex consistent with a metastasis (Figure 2 ). The patient refused further intervention and developed a complete right oculomotor palsy prior to her death 3 months later.
Discussion
Perhaps, the most common eye-related physical sign in the context of metastatic cancer is cranial nerve palsy, either related to a physical metastasis in the course of the affected cranial nerve or as a paraneoplastic phenomenon. 1 While lesions of the oculomotor nerve or its nucleus may result in associated pupillary abnormalities, the finding of a RAPD is an uncommon isolated clinical sign as a presenting feature of metastatic malignancy.
This pupillary sign is characterized by the presence of a normal bilateral pupillary response when the normal eye is illuminated, but when the light is quickly moved to the abnormal side there is pupillary dilatation. 2 The nerve fibres of the afferent limb of the pupillary light reflex leave the visual pathway prior to the lateral geniculate body without The key features of a raised plasma D-dimer concentration, a prolonged prothrombin time and reduced plasma fibrinogen concentration associated with a reduced platelet concentration are diagnostic of chronic DIC.
synapsing, and reach the dorsal midbrain. From here connexions to the effector arm of the reflex are made which complete the reflex arc. Illumination of the abnormal eye results in an impaired direct dilatory response to light, which is augmented by a normal indirect dilatory response in the abnormal eye. Asymmetrical disorders of the optic nerve or chiasmatic lesions are most likely to give rise to a RAPD, while disorders of the retina must be substantial and readily visible, to give rise to any RAPD.
The causes of a RAPD can be categorized in relation to the anatomical site of the lesion ( Table 2 ). The most common causes are stated to be optic nerve pathology, disorders of the optic tract and significant retinal disease. 3 Pathologies that affect the optic nerve and result in a rapid reduction in visual acuity are most usually due to optic neuritis or optic nerve ischaemia/ infarction, while compressive lesions are likely to give rise to slowly evolving visual field defects.
In those with rapid onset visual loss with an RAPD, optic neuritis typically affects individuals in the third decade onwards until the fifth decade, while ION is much more common from the sixth decade onwards. ION occurs when the blood supply of the optic nerve via the posterior ciliary artery and the circle of Zinn-Haller is disrupted by atherosclerotic disease [non-arteritic ION (NAION)], or vasculitis most commonly due to giant cell arteritis [arteritic ION (AION)]. 3 However, intravascular thrombosis of small vessels is a key feature of DIC and may manifest as either large-vessel arterial or venous thrombosis, as well as microvascular thrombosis. 4 In those patients with an RAPD and progressive visual loss, the possibility of a compressive lesion of the optic nerve, chiasm or even optic tract is more likely. Lesions of the orbital apex may often have associated features such as proptosis, the presence of optociliary shunt vessels, limitation of ocular movements and diplopia, cheimosis and periorbital puffiness, gaze-evoked amaurosis and facial pain, although the presence of all of these lesions is highly unusual.
In our first case, microvascular thrombosis of the left posterior ciliary artery due to underlying DIC was thought to be the cause of the visual loss in the left eye due to the development of NAION. In the second case, while there was no clear history of progressive visual loss, the prolonged duration of visual loss without any recovery, and the presence of unilateral optic atrophy in the eye with the RAPD raised the possibility of a compressive lesion of the optic nerve, which was confirmed on non-invasive imaging.
The RAPD is an important clinical sign, which can be readily elicited at the bedside. Examination for the presence of a RAPD is a fundamental part of the ocular examination and takes only a few seconds to perform. The presence of an RAPD is likely to be of clinical significance, particularly in the presence of ipsilateral visual loss or visual symptoms, and should prompt clinicians to be aware of the possibility of both local and distant diseases which may give rise to the development of a detectable RAPD.
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